Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Language
Publication year range
1.
Int J Obes (Lond) ; 30(4): 704-10, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16314877

ABSTRACT

OBJECTIVE: Peanut consumption may improve lipid profiles without promoting weight gain. Both properties have been attributed to their high-unsaturated fat content. Mono and polyunsaturated fatty acids reportedly hold stronger satiety value than saturated fats and may help appetite control. This study investigated the effects of chronic peanut oil consumption on appetite and food choice. RESEARCH METHODS AND PROCEDURES: A total of 129 healthy adults from three countries (Brazil, Ghana and US) were randomly assigned to one of four treatment arms: consumption of peanut oil, olive oil or safflower oil as 30% of individual resting energy expenditure (REE) for 8 weeks or no dietary intervention. Participants received no other dietary guidance. They completed appetite questionnaires eliciting information about hunger, fullness, desire to eat, and prospective consumption during all waking hours for 1 day at weeks 2 and 6 and for 1 or 3 days at weeks 0, 4 and 8. Diet records were completed at weeks 0, 4 and 8. RESULTS: No differences in appetitive ratings were observed over the 8-week trial. There were no significant treatment by time interactions. Total caloric intake was significantly higher at week 8 relative to baseline (F=10.08, P<0.05). The increases for each treatment were: peanut oil=197+/-114; olive oil=237+/-121; safflower oil=274+/-90; control=75+/-71. Free-feeding intake, an index of dietary compensation, was reduced significantly at weeks 4 and 8 compared to baseline (F=9.08, P<0.00). The declines (compensation scores) were (kcals): peanut oil=-208+/-105 (46%); olive oil=-235+/-105 (50%); safflower oil=-186+/-102 (44%). There were no significant differences across countries in appetite ratings. DISCUSSION: A prior intervention with whole peanuts reported a dietary compensation score of 66% over 8 weeks, this compares to a 46% compensation score observed with peanut oil. Our data suggests that the lipid fraction in peanuts elicits a weak effect on satiety.


Subject(s)
Appetite/drug effects , Dietary Fats, Unsaturated/pharmacology , Feeding Behavior/drug effects , Plant Oils/pharmacology , Adult , Brazil , Diet , Diet Records , Dietary Fats, Unsaturated/administration & dosage , Energy Metabolism/physiology , Female , Ghana , Humans , Male , Olive Oil , Peanut Oil , Plant Oils/administration & dosage , Safflower Oil/administration & dosage , Safflower Oil/pharmacology , Surveys and Questionnaires , United States
2.
Nutr. clín. diet. hosp ; 20(3): 102-110, mayo 2000. tab
Article in En | IBECS | ID: ibc-5161

ABSTRACT

Fue utilizado 40 g de una sopa deshidratada rica en fibra en 24 individuos adultos hipercolesterolémicos de ambos sexos durante 30 días para evaluar su efecto sobre los niveles sericos de lípidos y glucosa. El producto fue hecho de habas rojas, harina de soja desengrasada, fibra de soja, salvado de avena, cebolla y especias. Los análisis antropornétricos y bioquímicos fueron realizados en los días 0, 15 y 30 del ensayo. La evaluación de la dieta fue llevada a cabo antes y después de 15 días en dieta de sopa. Los sujetos no cambiaron su hábito alimentario en el período del estudio, sin embargo, la ingesta de la fibra y de la proteína de la dieta fueron aumentadas (p<0.04 y p<0.001, respectivamente). Los sujetos no mostraron cambios significativos en su peso corporal o en el índice de masa corporal, aunque disminuyeron (p<0.05) su porcentaje de grasa corporal total después de 30 días en dieta de sopa. Hubo una reducción significativa en las cifras del colesterol total, de los triglicéridos y el colesterol- VLDL (días 15 y 3 0), y en el colesterol-LDL y la glucosa plasmática (30 días). El colesterol-HDL no fue afectado de manera significativa por la dieta de sopa. Se concluye que este producto es una alternativa para el control dietético de los sujetos hipercolesterolémicos (AU)


Subject(s)
Adult , Female , Male , Middle Aged , Humans , Hypercholesterolemia/diet therapy , Lipids/blood , Glucose/analysis , Dietary Fiber/administration & dosage , Body Mass Index , Weight Loss
SELECTION OF CITATIONS
SEARCH DETAIL